John has over 25 years of experience in biomedical research.  He was a founding team member at LifeMine Therapeutics, a biotech leveraging genomics for next-generation drug discovery, targeting the primary cellular drivers of multiple diseases. Dr. Biggins was previously on the faculty of Chemistry at Hofstra University and has past affiliations with Rockefeller University, Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center, University of Wisconsin-Madison, and University of Delaware.  He enjoys catching Pokémon with his son.